Peter Scheurich相关文献与解析，生知库 | 链接生命科学的每一步

Daniela Stöhr, Jens O Schmid, Tobias B Beigl, Alexandra Mack, Daniela S Maichl, Kai Cao, Beate Budai, Gavin Fullstone, Roland E Kontermann, Thomas E Mürdter, Stephen W G Tait, Cathrin Hagenlocher, Nadine Pollak, Peter Scheurich, Markus Rehm

肿瘤

肿瘤细胞

FCM

IHC-P

发表日期：2020

文献求助收藏

Monovalent TNF receptor 1-selective antibody with improved affinity and neutralizing activity

具有改善的亲和力和中和活性的单价 TNF 受体 1 选择性抗体

期刊:MAbs

影响因子:5.6

doi:10.1080/19420862.2018.1524664

Fabian Richter, Kirstin A Zettlitz, Oliver Seifert, Andreas Herrmann, Peter Scheurich, Klaus Pfizenmaier, Roland E Kontermann

Bcl-2-mediated control of TRAIL-induced apoptotic response in the non-small lung cancer cell line NCI-H460 is effective at late caspase processing steps

Bcl-2 介导控制非小细胞肺癌细胞系 NCI-H460 中 TRAIL 诱导的细胞凋亡反应在晚期 caspase 处理步骤中有效

期刊:PLoS One

影响因子:2.9

doi:10.1371/journal.pone.0198203

Lubna Danish, Dirke Imig, Frank Allgöwer, Peter Scheurich, Nadine Pollak

Selective Blocking of TNF Receptor 1 Attenuates Peritoneal Dialysis Fluid Induced Inflammation of the Peritoneum in Mice

选择性阻断 TNF 受体 1 可减轻小鼠腹膜透析液诱发的腹膜炎症

期刊:PLoS One

影响因子:2.9

doi:10.1371/journal.pone.0163314

Florian Kälble, Janine Damaske, Danijela Heide, Iris Arnold, Fabian Richter, Olaf Maier, Ulrich Eisel, Peter Scheurich, Klaus Pfizenmaier, Martin Zeier, Vedat Schwenger, Julia Ranzinger

信号转导

发表日期：2016

文献求助收藏

Dominant negative effects of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 4 on TRAIL receptor 1 signaling by formation of heteromeric complexes

肿瘤坏死因子 (TNF) 相关凋亡诱导配体 (TRAIL) 受体 4 通过形成异源复合物对 TRAIL 受体 1 信号传导产生显性负面影响

期刊:Journal of Biological Chemistry

影响因子:4

doi:10.1074/jbc.M114.559468

Simon Neumann, Jan Hasenauer, Nadine Pollak, Peter Scheurich

An anti-TNFR1 scFv-HSA fusion protein as selective antagonist of TNF action

抗 TNFR1 scFv-HSA 融合蛋白作为 TNF 作用的选择性拮抗剂

期刊:Protein Engineering Design & Selection

影响因子:2.6

doi:10.1093/protein/gzt044

Verena Berger, Fabian Richter, Kirstin Zettlitz, Felix Unverdorben, Peter Scheurich, Andreas Herrmann, Klaus Pfizenmaier, Roland E Kontermann

信号转导

发表日期：2013

文献求助收藏

The transmembrane domains of TNF-related apoptosis-inducing ligand (TRAIL) receptors 1 and 2 co-regulate apoptotic signaling capacity

TNF 相关凋亡诱导配体 (TRAIL) 受体 1 和 2 的跨膜结构域共同调节凋亡信号传导能力

期刊:PLoS One

影响因子:2.9

doi:10.1371/journal.pone.0042526

Simon Neumann, Tobias Bidon, Marcus Branschädel, Anja Krippner-Heidenreich, Peter Scheurich, Malgorzata Doszczak

A TNF receptor 2 selective agonist rescues human neurons from oxidative stress-induced cell death

TNF 受体 2 选择性激动剂可拯救人类神经元免于氧化应激诱导的细胞死亡

期刊:PLoS One

影响因子:2.9

doi:10.1371/journal.pone.0027621

Roman Fischer, Olaf Maier, Martin Siegemund, Harald Wajant, Peter Scheurich, Klaus Pfizenmaier

Stress-induced TRAILR2 expression overcomes TRAIL resistance in cancer cell spheroids

应激诱导的 TRAILR2 表达可克服癌细胞球体中的 TRAIL 抗性

Monovalent TNF receptor 1-selective antibody with improved affinity and neutralizing activity

具有改善的亲和力和中和活性的单价 TNF 受体 1 选择性抗体

Bcl-2-mediated control of TRAIL-induced apoptotic response in the non-small lung cancer cell line NCI-H460 is effective at late caspase processing steps

Bcl-2 介导控制非小细胞肺癌细胞系 NCI-H460 中 TRAIL 诱导的细胞凋亡反应在晚期 caspase 处理步骤中有效

Selective Blocking of TNF Receptor 1 Attenuates Peritoneal Dialysis Fluid Induced Inflammation of the Peritoneum in Mice

选择性阻断 TNF 受体 1 可减轻小鼠腹膜透析液诱发的腹膜炎症

Dominant negative effects of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 4 on TRAIL receptor 1 signaling by formation of heteromeric complexes

肿瘤坏死因子 (TNF) 相关凋亡诱导配体 (TRAIL) 受体 4 通过形成异源复合物对 TRAIL 受体 1 信号传导产生显性负面影响

An anti-TNFR1 scFv-HSA fusion protein as selective antagonist of TNF action

抗 TNFR1 scFv-HSA 融合蛋白作为 TNF 作用的选择性拮抗剂

The transmembrane domains of TNF-related apoptosis-inducing ligand (TRAIL) receptors 1 and 2 co-regulate apoptotic signaling capacity

TNF 相关凋亡诱导配体 (TRAIL) 受体 1 和 2 的跨膜结构域共同调节凋亡信号传导能力

A TNF receptor 2 selective agonist rescues human neurons from oxidative stress-induced cell death

TNF 受体 2 选择性激动剂可拯救人类神经元免于氧化应激诱导的细胞死亡